- Home
- ANTX vs WVVI Comparison
ANTX vs WVVI Comparison
Compare ANTX & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- WVVI
- Stock Information
- Founded
- ANTX 2017
- WVVI 1983
- Country
- ANTX United States
- WVVI United States
- Employees
- ANTX N/A
- WVVI N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- ANTX Health Care
- WVVI Consumer Staples
- Exchange
- ANTX Nasdaq
- WVVI Nasdaq
- Market Cap
- ANTX 33.2M
- WVVI 28.2M
- IPO Year
- ANTX 2022
- WVVI N/A
- Fundamental
- Price
- ANTX $1.10
- WVVI $4.81
- Analyst Decision
- ANTX Buy
- WVVI
- Analyst Count
- ANTX 2
- WVVI 0
- Target Price
- ANTX $2.00
- WVVI N/A
- AVG Volume (30 Days)
- ANTX 95.4K
- WVVI 26.5K
- Earning Date
- ANTX 08-12-2025
- WVVI 08-12-2025
- Dividend Yield
- ANTX N/A
- WVVI N/A
- EPS Growth
- ANTX N/A
- WVVI N/A
- EPS
- ANTX N/A
- WVVI N/A
- Revenue
- ANTX N/A
- WVVI $38,520,945.00
- Revenue This Year
- ANTX N/A
- WVVI N/A
- Revenue Next Year
- ANTX N/A
- WVVI N/A
- P/E Ratio
- ANTX N/A
- WVVI N/A
- Revenue Growth
- ANTX N/A
- WVVI N/A
- 52 Week Low
- ANTX $0.87
- WVVI $3.17
- 52 Week High
- ANTX $3.07
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- ANTX 48.42
- WVVI 30.03
- Support Level
- ANTX $1.05
- WVVI $5.21
- Resistance Level
- ANTX $1.10
- WVVI $5.75
- Average True Range (ATR)
- ANTX 0.04
- WVVI 0.28
- MACD
- ANTX 0.00
- WVVI -0.05
- Stochastic Oscillator
- ANTX 50.00
- WVVI 10.00
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.